Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0279 | 0.32 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0279 | 0.32 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0279 | 0.32 | 0.2742 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0099 | 0.0632 | 1 |
Brugia malayi | YY1-associated factor 2 | 0.0099 | 0.0632 | 0.1974 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.0792 | 0.2476 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0632 | 0.1974 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0279 | 0.32 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0632 | 0.1974 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0099 | 0.0632 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0055 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0632 | 0.1974 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0099 | 0.0632 | 0.1974 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0099 | 0.0632 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0099 | 0.0632 | 0.1974 |
Schistosoma mansoni | hypothetical protein | 0.0279 | 0.32 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.011 | 0.0792 | 0.0625 |
Schistosoma mansoni | brg-1 associated factor | 0.0279 | 0.32 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0279 | 0.32 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0279 | 0.32 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0099 | 0.0632 | 0.1974 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0099 | 0.0632 | 0.1974 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0632 | 0.1974 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0279 | 0.32 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0279 | 0.32 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0279 | 0.32 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0279 | 0.32 | 0.2742 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0279 | 0.32 | 0.2742 |
Leishmania major | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0754 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0279 | 0.32 | 0.2742 |
Schistosoma mansoni | hypothetical protein | 0.0279 | 0.32 | 1 |
Onchocerca volvulus | 0.0279 | 0.32 | 1 | |
Brugia malayi | brahma associated protein 60 kDa | 0.0279 | 0.32 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0279 | 0.32 | 0.2742 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0279 | 0.32 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0099 | 0.0632 | 1 |
Onchocerca volvulus | 0.011 | 0.0792 | 0.0625 | |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0279 | 0.32 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0099 | 0.0632 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0099 | 0.0632 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0099 | 0.0632 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0099 | 0.0632 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0279 | 0.32 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0279 | 0.32 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0099 | 0.0632 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.0632 | 0.1974 |
Chlamydia trachomatis | SWIB complex protein | 0.0279 | 0.32 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0279 | 0.32 | 0.2742 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0099 | 0.0632 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0279 | 0.32 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 26.6795 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.